**REGISTERED CHARITY NUMBER: 1052205** ## **REPORT OF THE TRUSTEES AND** ## **UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2022** ## **FOR** ## **CARING CANCER TRUST** Garbetts (IOW) Limited Exchange House St Cross Lane Newport Isle of Wight PO30 5BZ **CARING CANCER TRUST** **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2022** **----- Start of picture text -----**
Page
Report of the Trustees 1 to 3
Independent Examiner's Report 4
Statement of Financial Activities 5
Balance Sheet 6
Notes to the Financial Statements 7 to 12
Detailed Statement of Financial Activities 13 to 14
**----- End of picture text -----**
**CARING CANCER TRUST** **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2022** The trustees present their report with the financial statements of the charity for the year ended 31 March 2022. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). ## **OBJECTIVES AND ACTIVITIES** ## **Objectives and aims** To fund ethical original and non-animal tested research into cancer prevention, treatment and cure and to provide information on cancer prevention and cure. To relieve sickness and to help persons recover from cancer, in particular, but not exclusively, for children with cancer. ## **Public benefit** All the activities of the Trust focus on delivering community benefit and are in accordance with the objects of the Trust. The Trustees have complied with their duty to have due regard to the Charity Commission's public benefit guidance when exercising any powers or duties to which the guidance is relevant. ## **ACHIEVEMENT AND PERFORMANCE** ## **Chairman's Report** Despite Covid effects on donations, CCT has been able to maintain and expand its Animal-free Research on cancer and individual cancer support during 2021. The continuing pandemic has caused us to again to regretfully cancel our programme of CCT Youth2Go Holiday groups of Physical and Creative Adventure for children in recovery from cancer. CCT has however therefore expanded its support for cancer research and individual adult cancer sufferers. CCT has continued to support the work carried out by the University of Manchester's Viral Oncology Laboratory by providing funding which has enabled the formation of a university spin-out company Ravan Bio Ltd. Ravan has continued the CCT funded work on cervical cancer prevention by working directly with New Zealand's largest pharmaceutical company Douglas Pharmaceuticals. The product of these endeavours is predicted to enter phase 2 clinical trials in 2023. In addition, Ravan Bio has embarked on an entirely new project aimed at preventing many types of cancer by developing treatments which arrest, reverse or slow-down the ageing process. It is a fact that the vast majority of human cancers are associated with old age. Thus, Ravan is investigating the prevention of cancer by targeting the ageing process itself and they have recently had some success with this goal. It is significant that targeting the ageing process is not just for the benefit of older people since it also has relevance to prevention of cancer in children and young adults. To explain, cancers are often caused by agents which artificially accelerate cellular ageing, such as radiation, which is why children treated with radiotherapy for one type of cancer can develop different types of cancer later in life. Ravan Bio is led by the former heads of the University Viral Oncology Laboratories under Professor Ian and Dr. Lynne Hampson. Page 1 **CARING CANCER TRUST** **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2022** UK's cancer mortality rates are among the highest of any developed nation. Cancer testing and therefore cancer diagnoses are down as a result of the Covid pandemic. CCT are therefore focussing on research which is aimed at Cancer Prevention. This has been a second difficult year for small charities like Caring Cancer Trust. We could not have survived and progressed though the pandemic without the dedicated work of our unpaid volunteers who manage and run the charity, and the support of our many charity friends. ## **Ian MacWatt** Hon. Chairman ## **FINANCIAL REVIEW** ## **Treasurer's report** As with most UK charities, CCT's charity shop and donation income and consequent outgoings in expenses and charitable causes have been dominated by the Covid pandemic. Charity marathons and other donation collection events have been cancelled. The pandemic, together with the Government High Street closures, caused considerable loss of shopping footfall in the High Street when it was open, and our two charity shops took only £8,037 for the year. However, as CCT is totally run by unpaid volunteers the charity has not been faced with the problem of the salaries for Charity Shop Managers and other relevant costs that have afflicted so many charities during the pandemic. CCT received one legacy during the year of £20,000. Other donations were £4,741. A government Covid furlough payment of £75,595.90 was received from the University of Manchester to cover the furlough payments of Dr. He, whose salary was financed by CCT. This enabled us to donate £50,000 to cancer research at Manchester's Ravan Bio together with £10,000 from the CCT account. Total spent on Research and Support was £63,201 against total expenses for the year of £99,468. Bank assets at the financial year end were £97,551. Other assets including shop stock, car and equipment, were £11,374 **.** Charity debts were £6,932. ## **Donald Haver** Hon Treasurer ## **Reserves policy** The board of trustees aims to maintain at least three months running costs in unrestricted reserves at any given time. The reserves are held to cover the variable nature of cash flow, to safeguard future operations and to enable the charity to consider new projects. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is controlled by its governing document, a deed of trust, adopted on 16 January 1996 and as amended on 27 June 2004 and constitutes an unincorporated charity. ## **Organisation** The trustees who served during the year are set out below. The trustees meet regularly and meetings are presided over by a Chairman who is appointed annually. New members are elected by the board on a majority vote. Page 2 CARING CANCER TrUST REPORT OF ThE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2022 REFERENCE AND ADMINISTRATIVE D￿AlLs Registered Charity number 1052205 PrintÉpal address 165 High Street Ryde Isle of WiEht P033 2HS Trustee5 Mr l Macwatt Secretary Mr R Fiddes Mr D P Haver Mrs A Matwatt Trustee L Stewart Independent Examlner Mark P3xton FCCA Garbètts IIOWI Limited Exchange Huuse st Cross Lanè Newport Isle of Wight P030 5BZ Approved by order of the board of trustees on . and signed on its bèhalf bv: Mr l M3cWatt-TrustÈe Page 3 INDEPENDENT EXAMINER'S REPORTTO THE TRUSTEES OF CARING CANCER TRLIST Independent examlner's report to the trustees of Caring CanterTrusl I report to the charity trustees on my examination ol the accounts of Carin8 Cancer Trust (thè Trust) for ihe year ended 31 March 2022. Respons]bllltles and basls of report As the charity trustees of the Trust you are responsiblè for the preparation of the accounts in accordance with the requirements of the Charities Act 20111'the Act'l. I report in respect of my examinalion of the Trust's accounts cairied out under section 145 of the Act and in carrying out my examÈnation I have followed all applicable Directions given by the Charity Commission under section 1451sllbl of the Act. Independent examiner'5 Statement I have completèd my èxamination. I confirm that no materlal matters have come to my attention in connection with the examinatlon giving me cause to believe that in any material respert= accounting records wère not kèpt in respect of the Trust a5 required by section 130 of the Act; or the accounts do not accord with those records,. or the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Report51 Regulations 2￿8 other than any Yequirement that the accounts give a true and fair view which is not a mattèr tonsidered as part of an independent examination. I have no toncÈrns and have come across no other matters in connettion with the examinatÉon to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Mark PaxEon FCCA Garbetts IIOWI LimÈted Exchange House St Cross Lane Newport Isle of Wight P030 5BZ Date.. Page 4 **CARING CANCER TRUST** **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2022** |2022
Unrestricted
fund
Notes
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
24,741
**Charitable activities**
Manchester University
75,597
General
5,334
Other trading activities
2
8,037
Investment income
3
7
**Total**
113,716
**EXPENDITURE ON**
Raising funds
17,006
**Charitable activities**
Manchester University
60,000
General
22,462
**Total**
99,468
**NET INCOME/(EXPENDITURE)**
14,248
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
87,745
**TOTAL FUNDS CARRIED FORWARD**
101,993|2021
Total
funds
£
4,269
-
39,338
8,898
27
52,532
17,145
20,000
15,455
52,600
(68)
87,813
87,745| |---|---| The notes form part of these financial statements Page 5 CARING CANCER TRU BALANCE SHEET 31 MARCH 2022 2022 Unrestricted fund 2021 Total funds Notes FIXED AssErs Tangible assets 4,665 5,854 CURRENT ASSErs Stocks Debtors Cash at bank and in hand 2,5CKJ 4,209 97,551 2,000 3,564 83,703 104,260 90,267 CREDITORS Amounts falling due within one year 16,9321 18,3761 NET CURRENT ASS￿5 97.328 81,891 TOTAL ASS￿5 LESS CURRENT LIABILIYIES 101,993 87,745 N￿ASSETs 101,993 87,745 FUNDS Unrestricted fund5 li 101,993 87.745 TOTAL FUNDS 101.993 87,745 The financial statements were approved by the Board of TIu5tees and authori5ed for issue on and were signed on Éts behalf by= MrDPHav Trustee The notes form part of these financial statements Page 6 **CARING CANCER TRUST** **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2022** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. ## **Tangible fixed assets** Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. Plant and machinery - 25% on reducing balance Motor vehicles - 25% on reducing balance Computer equipment - 33% on cost ## **Stocks** Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. ## **Taxation** The charity is exempt from tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **Donated goods** The value of donated stock can be measured reliably at fair value and has been recognised in the year of donation. continued... Page 7 **CARING CANCER TRUST** **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2022** ## **2. OTHER TRADING ACTIVITIES** |**2.**
**OTHER TRADING ACTIVITIES**|| |---|---| |Shop income|2022
2021
£
£
8,037
8,898| |**3.**
**INVESTMENT INCOME**
Investment income and interest|2022
2021
£
£
7
27| ## **4. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 31 March 2022 nor for the year ended 31 March 2021. ## **Trustees' expenses** There were no trustees' expenses paid for the year ended 31 March 2022 nor for the year ended 31 March 2021. ## **5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** |Unrestricted
fund
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
4,269
**Charitable activities**
General
39,338
Other trading activities
8,898
Investment income
27| |---| |**Total**
52,532| |**EXPENDITURE ON**
Raising funds
17,145
**Charitable activities**
Manchester University
20,000
General
15,455| |**Total**
52,600| |**NET INCOME/(EXPENDITURE)**
(68)| continued... Page 8 **CARING CANCER TRUST** **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2022** ## **5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued** |**RECONCILIATION OF FUNDS**
**Total funds brought forward**
**TOTAL FUNDS CARRIED FORWARD**
**TANGIBLE FIXED ASSETS**
Plant and
machinery
£
**COST**
At 1 April 2021
13,302
Additions
-
At 31 March 2022
13,302
**DEPRECIATION**
At 1 April 2021
11,466
Charge for year
459
At 31 March 2022
11,925
**NET BOOK VALUE**
At 31 March 2022
1,377
At 31 March 2021
1,836|Unrestricted
fund
£
87,813
87,745
Motor
Computer
vehicles
equipment
Totals
£
£
£
12,699
11,214
37,215
-
409
409
12,699
11,623
37,624
8,681
11,214
31,361
1,004
135
1,598
9,685
11,349
32,959
3,014
274
4,665
4,018
-
5,854| |---|---| ## **6. TANGIBLE FIXED ASSETS** continued... Page 9 **CARING CANCER TRUST** **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2022** **----- Start of picture text -----**
7. STOCKS
2022 2021
£ £
Stocks 2,500 3,000
8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£ £
Other debtors 2,628 2,628
Prepayments 1,581 936
4,209 3,564
9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£ £
Other creditors 6,932 8,376
10. LEASING AGREEMENTS
Minimum lease payments under non-cancellable operating leases fall due as follows:
2022 2021
£ £
Within one year 15,200 15,200
Between one and five years 26,600 41,800
41,800 57,000
11. MOVEMENT IN FUNDS
Net
movement At
At 1.4.21 in funds 31.3.22
£ £ £
Unrestricted funds
General fund 87,745 14,248 101,993
TOTAL FUNDS 87,745 14,248 101,993
**----- End of picture text -----**
continued... Page 10 **CARING CANCER TRUST** **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2022** ## **11. MOVEMENT IN FUNDS - continued** Net movement in funds, included in the above are as follows: |Incoming
resources
£
**Unrestricted funds**
General fund
113,716|Resources
expended
£
(99,468)|Movement
in funds
£
14,248| |---|---|---| |**TOTAL FUNDS**
113,716|(99,468)|14,248| |**Comparatives for movement in funds**
At 1.4.20
£
**Unrestricted funds**
General fund
87,813|Net
movement
in funds
£
(68)|At
31.3.21
£
87,745| |**TOTAL FUNDS**
87,813|(68)|87,745| |Comparative net movement in funds, included in the above are as follows:
Incoming
resources
£
**Unrestricted funds**
General fund
52,532|Resources
expended
£
(52,600)|Movement
in funds
£
(68)| |**TOTAL FUNDS**
52,532|(52,600)|(68)| continued... Page 11 **CARING CANCER TRUST** **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2022** ## **11. MOVEMENT IN FUNDS - continued** A current year 12 months and prior year 12 months combined position is as follows: |At 1.4.20
£
**Unrestricted funds**
General fund
87,813|Net
movement
At
in funds
31.3.22
£
£
14,180
101,993| |---|---| |**TOTAL FUNDS**
87,813|14,180
101,993| A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: |**Unrestricted funds**
General fund
**TOTAL FUNDS**|Incoming
resources
£
166,248
166,248|Resources
Movement
expended
in funds
£
£
(152,068)
14,180
(152,068)
14,180| |---|---|---| ## **12. RELATED PARTY DISCLOSURES** ## **Ian McWatt** Ian McWatt is a trustee of Caring Cancer Trust. During the year Ian McWatt introduced funds totalling £1,151 (2021: £3,305) and withdrew funds totalling £2,595 (2021: £Nil). At 31 March 2022, Caring Cancer Trust owed Ian McWatt £4,530 (2021: owing from Ian McWatt £5,975). Page 12 **CARING CANCER TRUST** **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2022** |**INCOME AND ENDOWMENTS**
**Donations and legacies**
Donations
**Other trading activities**
Shop income
**Investment income**
Investment income and interest
**Charitable activities**
Grants
Grants to institutions refunded
**Total incoming resources**
**EXPENDITURE**
**Other trading activities**
Opening stock
Purchases
Shop running costs
Closing stock
**Charitable activities**
Insurance
Light and heat
Telephone
Postage and stationery
Advertising
Sundries
Motor and travel
Computer costs
Storage
Carried forward|2022
£
24,741
8,037
7
5,334
75,597
80,931
113,716
500
864
15,642
-
17,006
727
394
802
166
6,554
46
4,364
1,906
107
15,066|2021
£
4,269
8,898
27
39,338
-
39,338
52,532
500
880
16,265
(500)
17,145
735
324
727
702
840
81
1,445
1,584
1,313
7,751| |---|---|---| This page does not form part of the statutory financial statements Page 13 **CARING CANCER TRUST** ## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2022** |**Charitable activities**
Brought forward
Other charitable payments
Child cancer support
Plant and machinery
Motor vehicles
Computer equipment
Grants to institutions
**Support costs**
**Finance**
Bank charges
**Governance costs**
Accountancy
Total resources expended
**Net income/(expenditure)**|2022
£
15,066
25
3,176
459
1,005
135
60,000
79,866
196
2,400
99,468
14,248|2021
£
7,751
-
2,920
612
1,339
159
20,200
32,981
74
2,400
52,600
(68)| |---|---|---| This page does not form part of the statutory financial statements Page 14